nDatalyze Corp.

CNSX:NDAT Stock Report

Market Cap: CA$3.8m

nDatalyze Valuation

Is NDAT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Book vs Peers

  • Price-To-Book vs Industry

  • Price-To-Book vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NDAT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate NDAT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate NDAT's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NDAT?

Key metric: As NDAT barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for NDAT. This is calculated by dividing NDAT's market cap by their current book value.
What is NDAT's PB Ratio?
PB Ratio5.6x
BookCA$687.92k
Market CapCA$3.82m

Price to Book Ratio vs Peers

How does NDAT's PB Ratio compare to its peers?

The above table shows the PB ratio for NDAT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PBEstimated GrowthMarket Cap
Peer Average3.9x
TELE Telecure Technologies
0.9xn/aCA$7.6m
RHT Reliq Health Technologies
3.5xn/aCA$47.3m
HMRK Highmark Interactive
8.4xn/aCA$617.1k
AVCR Avricore Health
2.7xn/aCA$6.1m
NDAT nDatalyze
5.6xn/aCA$3.8m

Price-To-Book vs Peers: NDAT is expensive based on its Price-To-Book Ratio (5.6x) compared to the peer average (3.1x).

Price to Book Ratio vs Industry

How does NDAT's PB Ratio compare vs other companies in the CA Healthcare Services Industry?

0 CompaniesPrice / BookEstimated GrowthMarket Cap
No more companies available in this PB range
NDAT 5.6xIndustry Avg. 1.5xNo. of Companies1PB01.22.43.64.86+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Book vs Industry: NDAT is expensive based on its Price-To-Book Ratio (5.6x) compared to the North American Healthcare Services industry average (1.5x).

Price to Book Ratio vs Fair Ratio

What is NDAT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NDAT PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio5.6x
Fair PB Ration/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate NDAT's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

NeuPath Health

CA$9.0m

Provides chronic pain management services in Canada.

NPTH

CA$0.17

7D

6.3%

1Y

9.7%

Medical Facilities

CA$369.6m

Through its subsidiaries, owns and operates specialty hospitals and ambulatory surgery center in the United States.

DR

CA$15.55

7D

3.2%

1Y

79.1%

Carebook Technologies

CA$6.2m

Engages in the development and commercialization of digital health platforms for assessments, reporting, and targeted solutions in Canada, the United States, Europe, Latin America, Asia, and internationally.

CRBK

CA$0.05

7D

-37.5%

1Y

-28.6%